塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/08/24 | 6,158 | 6,208 | 6,148 | 6,166 | -18 | -0.3% | 372,500 |
2020/08/21 | 6,278 | 6,302 | 6,170 | 6,184 | -66 | -1.1% | 836,000 |
2020/08/20 | 6,180 | 6,250 | 6,171 | 6,250 | +80 | +1.3% | 696,900 |
2020/08/19 | 6,127 | 6,180 | 6,118 | 6,170 | +43 | +0.7% | 642,000 |
2020/08/18 | 6,111 | 6,164 | 6,084 | 6,127 | +16 | +0.3% | 1,051,600 |
2020/08/17 | 6,214 | 6,239 | 6,091 | 6,111 | -123 | -2% | 797,800 |
2020/08/14 | 6,210 | 6,244 | 6,191 | 6,234 | +32 | +0.5% | 692,500 |
2020/08/13 | 6,210 | 6,234 | 6,175 | 6,202 | +92 | +1.5% | 1,048,400 |
2020/08/12 | 6,111 | 6,138 | 6,064 | 6,110 | +26 | +0.4% | 955,600 |
2020/08/11 | 6,074 | 6,129 | 6,057 | 6,084 | +41 | +0.7% | 929,200 |
2020/08/07 | 6,124 | 6,149 | 6,001 | 6,043 | -33 | -0.5% | 771,200 |
2020/08/06 | 6,140 | 6,166 | 6,036 | 6,076 | -74 | -1.2% | 798,800 |
2020/08/05 | 6,231 | 6,285 | 6,097 | 6,150 | -62 | -1% | 1,161,900 |
2020/08/04 | 6,010 | 6,314 | 6,006 | 6,212 | +115 | +1.9% | 2,286,300 |
2020/08/03 | 6,270 | 6,315 | 6,086 | 6,097 | -162 | -2.6% | 1,596,200 |
2020/07/31 | 6,445 | 6,449 | 6,257 | 6,259 | -186 | -2.9% | 1,182,900 |
2020/07/30 | 6,436 | 6,445 | 6,360 | 6,445 | +15 | +0.2% | 895,600 |
2020/07/29 | 6,400 | 6,451 | 6,357 | 6,430 | +30 | +0.5% | 783,400 |
2020/07/28 | 6,422 | 6,441 | 6,360 | 6,400 | +26 | +0.4% | 702,700 |
2020/07/27 | 6,376 | 6,398 | 6,305 | 6,374 | +3 | ±0% | 837,800 |
2020/07/22 | 6,375 | 6,400 | 6,258 | 6,371 | -67 | -1% | 1,133,900 |
2020/07/21 | 6,500 | 6,503 | 6,340 | 6,438 | +178 | +2.8% | 2,212,900 |
2020/07/20 | 6,154 | 6,264 | 6,133 | 6,260 | +106 | +1.7% | 679,800 |
2020/07/17 | 6,201 | 6,238 | 6,125 | 6,154 | -4 | -0.1% | 782,500 |
2020/07/16 | 6,348 | 6,348 | 6,155 | 6,158 | -163 | -2.6% | 1,240,900 |
2020/07/15 | 6,342 | 6,347 | 6,196 | 6,321 | +13 | +0.2% | 1,215,100 |
2020/07/14 | 6,300 | 6,375 | 6,280 | 6,308 | +61 | +1% | 1,134,200 |
2020/07/13 | 6,185 | 6,255 | 6,121 | 6,247 | +113 | +1.8% | 880,200 |
2020/07/10 | 6,198 | 6,242 | 6,128 | 6,134 | -67 | -1.1% | 1,568,300 |
2020/07/09 | 6,156 | 6,265 | 6,156 | 6,201 | -85 | -1.4% | 1,061,200 |
2020/07/08 | 6,350 | 6,432 | 6,271 | 6,286 | -81 | -1.3% | 1,091,400 |
2020/07/07 | 6,470 | 6,470 | 6,324 | 6,367 | -147 | -2.3% | 1,257,800 |
2020/07/06 | 6,590 | 6,590 | 6,489 | 6,514 | -91 | -1.4% | 980,200 |
2020/07/03 | 6,560 | 6,611 | 6,534 | 6,605 | +92 | +1.4% | 538,700 |
2020/07/02 | 6,559 | 6,607 | 6,485 | 6,513 | -22 | -0.3% | 1,146,700 |
2020/07/01 | 6,550 | 6,693 | 6,524 | 6,535 | -215 | -3.2% | 1,299,000 |
2020/06/30 | 6,751 | 6,779 | 6,684 | 6,750 | +92 | +1.4% | 1,127,600 |
2020/06/29 | 6,840 | 6,848 | 6,651 | 6,658 | -234 | -3.4% | 1,565,000 |
2020/06/26 | 6,853 | 6,915 | 6,842 | 6,892 | +46 | +0.7% | 1,153,300 |
2020/06/25 | 6,750 | 6,911 | 6,701 | 6,846 | -126 | -1.8% | 2,021,700 |
2020/06/24 | 7,028 | 7,119 | 6,966 | 6,972 | -75 | -1.1% | 1,476,100 |
2020/06/23 | 7,088 | 7,125 | 6,923 | 7,047 | -40 | -0.6% | 1,713,200 |
2020/06/22 | 7,151 | 7,183 | 7,040 | 7,087 | +150 | +2.2% | 2,299,500 |
2020/06/19 | 6,836 | 7,000 | 6,827 | 6,937 | +139 | +2% | 2,639,500 |
2020/06/18 | 6,767 | 6,834 | 6,681 | 6,798 | +22 | +0.3% | 1,422,900 |
2020/06/17 | 6,750 | 6,834 | 6,731 | 6,776 | -25 | -0.4% | 1,476,900 |
2020/06/16 | 6,633 | 6,871 | 6,576 | 6,801 | +266 | +4.1% | 2,000,400 |
2020/06/15 | 6,517 | 6,727 | 6,511 | 6,535 | +32 | +0.5% | 1,761,600 |
2020/06/12 | 6,293 | 6,537 | 6,231 | 6,503 | +68 | +1.1% | 2,270,500 |
2020/06/11 | 6,599 | 6,600 | 6,401 | 6,435 | -179 | -2.7% | 1,566,300 |
1151~
1200
件表示中 / 3694件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 236,600円 | +5.7% | +3.9% | 2.59% | 11.77倍 | 1.56倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 723,600円 | +2.2% | +10.2% | 1.66% | 13.90倍 | 1.40倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 140,800円 | +0.9% | +380.2% | 5.54% | 19.39倍 | 1.67倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 401,800円 | +1.7% | -2.9% | 3.98% | 26.36倍 | 1.38倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 218,900円 | -3.5% | -11.3% | 2.74% | 20.11倍 | 1.35倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム